Evidence about HUI and hemophilia in response to Young et al. “How well does the Canadian hemophilia outcomes‐kids' life assessment tool (CHO‐KLAT) measure the quality of life of boys with hemophilia?”

Publisher： John Wiley & Sons Inc

E-ISSN： 1545-5017|49|7|1047-1048

ISSN： 1545-5009

Source： PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol.49, Iss.7, 2007-12, pp. : 1047-1048

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Treatment outcomes, quality of life, and impact of hemophilia on young adults (aged 18–30 years) with hemophilia

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. S2, 2015-12 ,pp. : S3-S10

John Wiley & Sons Inc

Access to resources Recommend Favorite

Describing the quality of life of boys with haemophilia in China: Results of a multicentre study using the CHO‐KLAT

By  

HAEMOPHILIA, Vol. 24, Iss. 1, 2018-01 ,pp. : 113-119

John Wiley & Sons Inc

Access to resources Recommend Favorite

EQOFIX: a combined economic and quality‐of‐life study of hemophilia B treatments in France

By  

TRANSFUSION, Vol. 55, Iss. 7, 2015-07 ,pp. : 1787-1797

John Wiley & Sons Inc

Access to resources Recommend Favorite

Age at first joint bleed and bleeding severity in boys with severe hemophilia A: Canadian Hemophilia Primary Prophylaxis Study

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 9, Iss. 5, 2011-05 ,pp. : 1067-1069

John Wiley & Sons Inc

Access to resources Recommend Favorite

Half‐life extended factor VIII for the treatment of hemophilia A

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 13, Iss. S1, 2015-06 ,pp. : S176-S179

John Wiley & Sons Inc

Access to resources Recommend Favorite